|
|
|
|
Partnering with a CDMO with a strong Cell Line Development (CLD) foundation is essential for biopharma companies looking to transition a protein from development to commercialization efficiently. Here, we explore key factors in selecting the right CDMO partner.
|
|
|
|
|
Maruno et al. recently used sedimentation velocity analytical ultracentrifugation (SV-AUC) to analyze AAV size distributions across multiple wavelengths. This method separates species physically, enabling identification and quantification. Learn how to apply this technique in our on-demand webinar.
|
|
|
|
|
This webinar covers innovative platform technologies that boost bioprocessing efficiency, featuring end-to-end cell line development and advanced analytics to accelerate the development, characterization, and manufacturing of therapeutic proteins.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Turn Complexity Into Possibility With A Trusted CDMO Partner
|
Move past challenges to unlock new possibilities. Partner with an expert CDMO that brings innovative approaches, guidance, and advanced analytics to each stage of your project — from cell line development to manufacturing. Navigate development and manufacturing with confidence.
|
|
|
